Please provide your email address to receive an email when new articles are posted on . The FDA approved the first polypill designed for initial treatment of hypertension. Approval was based on the ...
More than half of Americans aged 40 and over have high blood pressure. There are typically no symptoms, but left untreated, it can be deadly. NPR's Allison Aubrey reports on new recommendations aimed ...
Please provide your email address to receive an email when new articles are posted on . Lifetime risk for hypertension is up to 90% among U.S. adults. Updated guidelines and a pipeline of novel drugs ...
Cardiovascular health promotion strategies are key to prevent hypertension in Black women. The primary approach of any antihypertensive treatment plan is education about lifestyle modifications. These ...
Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with ...
Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with ...
Diagnostic delays in hypertension lead to lower treatment rates and increased cardiovascular risk, with prescription rates decreasing as delays lengthen. Delayed diagnoses correlate with a higher risk ...
The data from the Launch-HTN trial, announced at the 34th European Meeting on Hypertension and Cardiovascular Protection, show that lorundrostat, an aldosterone synthase inhibitor, is a safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results